• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期和产后植入式心脏转复除颤器的安全性和有效性。

Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery.

机构信息

Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center, Suita, Japan.

出版信息

Circ J. 2013;77(5):1166-70. doi: 10.1253/circj.cj-12-1275. Epub 2012 Dec 29.

DOI:10.1253/circj.cj-12-1275
PMID:23291990
Abstract

BACKGROUND

There are few studies of pregnancy and delivery in patients with an implantable cardioverter-defibrillator (ICD). The purpose of this study was to investigate maternal and fetal outcome in these patients.

METHODS AND RESULTS

Six pregnant women with an ICD were retrospectively reviewed. All women underwent implantation of an ICD before pregnancy and delivered at the National Cerebral and Cardiovascular Center. The mean age at pregnancy and the mean follow-up period after ICD implantation were 28±3 years old and 5±3 years, respectively. There was no device-related complication during pregnancy. In 4 women, the number of tachyarrhythmias such as non-sustained ventricular tachycardia increased after the end of the second trimester of pregnancy and anti-arrhythmic medications were gradually increased. No patient received discharges or shocks from the ICD during pregnancy, however, and only one required anti-tachycardia pacing at 27 weeks' gestation. Mean gestational age at delivery was 37±2 weeks and all deliveries were by cesarean section, including 5 as emergency deliveries due to a fetal indication. After delivery, 2 mothers had reduced cardiac function and 1 received an ICD shock for the first time.

CONCLUSIONS

Pregnancy did not increase the risk of an ICD-related complication under appropriate management. Additional caution might be required in the postpartum period as well as during pregnancy and labor.

摘要

背景

目前鲜有关于植入式心脏复律除颤器(ICD)患者妊娠和分娩的研究。本研究旨在探讨此类患者的母婴结局。

方法和结果

回顾性分析了 6 例患有 ICD 的妊娠女性。所有女性均在妊娠前植入 ICD,并在国立循环器病研究中心分娩。妊娠时的平均年龄和 ICD 植入后的平均随访时间分别为 28±3 岁和 5±3 年。妊娠期间无器械相关并发症。4 例女性在妊娠后期,非持续性室性心动过速等快速性心律失常的次数增加,抗心律失常药物逐渐增加。然而,妊娠期间无患者 ICD 放电或电击,仅有 1 例在 27 周妊娠时需要抗心动过速起搏。分娩时的平均孕龄为 37±2 周,所有分娩均为剖宫产,其中 5 例因胎儿指征而行急症剖宫产。分娩后,有 2 位母亲心功能下降,1 位首次接受 ICD 电击。

结论

在适当的管理下,妊娠并未增加与 ICD 相关的并发症风险。在产后以及妊娠和分娩期间可能需要更加谨慎。

相似文献

1
Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery.妊娠期和产后植入式心脏转复除颤器的安全性和有效性。
Circ J. 2013;77(5):1166-70. doi: 10.1253/circj.cj-12-1275. Epub 2012 Dec 29.
2
Pregnancy in women with an implantable cardioverter-defibrillator: is it safe?植入式心脏复律除颤器女性患者的妊娠:安全吗?
Europace. 2014 Nov;16(11):1587-94. doi: 10.1093/europace/euu036. Epub 2014 Mar 3.
3
Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.小儿经皮心脏除颤器治疗:英国单中心经验,重点关注皮下除颤。
Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20.
4
Implantable cardioverter-defibrillators and pregnancy: a safe combination?植入式心脏复律除颤器与妊娠:安全组合?
Circulation. 1997 Nov 4;96(9):2808-12. doi: 10.1161/01.cir.96.9.2808.
5
Complications of permanent cardiac pacing in patients with persistent left superior vena cava.永存左上腔静脉患者永久性心脏起搏的并发症
Cardiol J. 2014;21(2):128-37. doi: 10.5603/CJ.a2014.0006. Epub 2014 Feb 14.
6
Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.SIMPLE 和 EFFORTLESS 研究中皮下植入式和经静脉植入式心脏复律除颤器治疗的倾向评分匹配比较。
Europace. 2018 Sep 1;20(FI2):f240-f248. doi: 10.1093/europace/euy083.
7
Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.真实世界中植入式心脏复律除颤器糖尿病患者的特征与结局:以色列植入式心脏复律除颤器注册研究结果
Cardiovasc Diabetol. 2016 Dec 1;15(1):160. doi: 10.1186/s12933-016-0478-2.
8
Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病女性的妊娠过程及结局
Heart. 2016 Feb 15;102(4):303-12. doi: 10.1136/heartjnl-2015-308624. Epub 2015 Dec 30.
9
The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.不再符合一级预防指征的患者在更换植入式心律转复除颤器发生器后植入式心律转复除颤器治疗的发生情况
J Cardiovasc Electrophysiol. 2016 Jun;27(6):724-9. doi: 10.1111/jce.12961. Epub 2016 Apr 20.
10
Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.适当的植入式心脏复律除颤器治疗在二级预防患者中的死亡率影响:前瞻性基于人群的登记处中一级预防患者死亡率的对比。
J Am Heart Assoc. 2017 Aug 19;6(8):e006220. doi: 10.1161/JAHA.117.006220.

引用本文的文献

1
Successful Management of a Pregnant Patient with Danon Cardiomyopathy.成功管理一名患有达农心肌病的孕妇患者。
Intern Med. 2024;63(5):681-686. doi: 10.2169/internalmedicine.1673-23.
2
Pregnancy Arrhythmias: Management in the Emergency Department and Critical Care.妊娠心律失常:急诊科及重症监护中的管理
J Clin Med. 2024 Feb 15;13(4):1095. doi: 10.3390/jcm13041095.
3
Long QT Syndrome Management during and after Pregnancy.长 QT 综合征的妊娠期间和产后管理。
Medicina (Kaunas). 2022 Nov 21;58(11):1694. doi: 10.3390/medicina58111694.
4
Usage of the wearable cardioverter-defibrillator during pregnancy.孕期可穿戴式心脏复律除颤器的使用。
Int J Cardiol Heart Vasc. 2022 Jun 3;41:101066. doi: 10.1016/j.ijcha.2022.101066. eCollection 2022 Aug.
5
Pregnancy in arrhythmogenic cardiomyopathy.致心律失常性右室心肌病患者的妊娠问题。
Herzschrittmacherther Elektrophysiol. 2021 Jun;32(2):186-198. doi: 10.1007/s00399-021-00770-7. Epub 2021 May 25.
6
Pregnancy in patients with implantable cardiac defibrillators.植入式心脏除颤器患者的妊娠问题。
Herzschrittmacherther Elektrophysiol. 2021 Jun;32(2):214-220. doi: 10.1007/s00399-021-00750-x. Epub 2021 May 10.
7
Management of Implantable Cardioverter-Defibrillators during Pregnancy-A Systematic Review.孕期植入式心脏复律除颤器的管理——一项系统评价
J Clin Med. 2021 Apr 14;10(8):1675. doi: 10.3390/jcm10081675.
8
Brazilian Cardiology Society Statement for Management of Pregnancy and Family Planning in Women with Heart Disease - 2020.巴西心脏病学会关于心脏病女性妊娠管理与计划生育的声明 - 2020年
Arq Bras Cardiol. 2020 Jun 1;114(5):849-942. doi: 10.36660/abc.20200406.
9
[Relevant aspects of the ESC guidelines for the management of cardiovascular diseases during pregnancy for obstetric anaesthesia (update 2018)].[欧洲心脏病学会(ESC)2018年更新版妊娠期心血管疾病管理指南中与产科麻醉相关的内容]
Anaesthesist. 2019 Jul;68(7):461-475. doi: 10.1007/s00101-019-0613-z.
10
Pregnancy and delivery in woman with implantable cardioverter-defibrillator: what we should know.植入式心脏复律除颤器女性患者的妊娠与分娩:我们应该了解的情况。
Pan Afr Med J. 2018 Jul 30;30:236. doi: 10.11604/pamj.2018.30.236.9995. eCollection 2018.